학술논문
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial
Document Type
Article
Author
Véron, Marie; Chevret, Sylvie; Grob, Jean-Jacques; Beylot-Barry, Marie; Saiag, Philippe; Fléchon, Aude; You, Benoit; Maubec, Eve; Jouary, Thomas; Toulemonde, Elise; Jamme, Philippe; Gambotti, Laëtitia; Lamrani-Ghaouti, Assia; Dupuy, Alain; Lebbe, Céleste; Seguin, Nicole Basset; Houede, Nadine; Leccia, Marie-Thérèse; Le Du, Fanny; de Pontville, Michel; Gaudy-Marquestre, Caroline; Guillot, Bernard; Simon, Clotilde; Marabelle, Aurélien; Mortier, Laurent
Source
In European Journal of Cancer December 2022 177:103-111
Subject
Language
ISSN
0959-8049